Tag: translational research
-
Gnome Sciences Unveils Promising ALS Results From Cancer Drug Study
Groundbreaking ALS Findings from a Cancer Drug Study Gnome Sciences, a leader in molecular pathology and translational research, announced a significant advance in the fight against amyotrophic lateral sclerosis (ALS). In a newly published study, researchers revealed that a cancer drug—originally developed to target tumor growth—demonstrated measurable neuroprotective effects in ALS models. The findings, produced…
-
ALS Breakthrough: Cancer Drug Shows Promise, Gnome Sciences Reports
Gnome Sciences Announces Promising ALS Research Gnome Sciences, a leader in molecular pathology and translational research, has announced encouraging results from a newly published study investigating the potential of a cancer drug in treating amyotrophic lateral sclerosis (ALS). The announcement, made in Columbus, Ohio, underscores a growing interest in repurposing oncology therapies to address complex…
-
Gnome Sciences Announces Cancer Drug Shows Promise for ALS Therapy in New Study
Breakthrough in ALS Research: A Cancer Drug Shows Promise In a notable advance for neurodegenerative disease research, Gnome Sciences, a leader in molecular pathology and translational studies, reports that a cancer drug demonstrates promising effects in models of amyotrophic lateral sclerosis (ALS). The company announced the findings following a newly published study that suggests the…
-
Surrey Neurologist Wins Award to Advance Parkinson’s Research
Recognition for Groundbreaking Parkinson’s Research in Surrey A Surrey Memorial Hospital neurologist has been honored for his important work in Parkinson’s disease research. Dr. Jason Chan has received the 2025 Michael Smith Health Research BC Health Professional-Investigator Award, underscoring the community’s commitment to advancing treatments and improving the lives of people living with Parkinson’s. The…
-
Surrey Neurologist Wins Prestigious Award to Accelerate Parkinson’s Disease Research
Surrey Neurologist Honored for Parkinson’s Disease Research In a significant milestone for Canadian medical research, Dr. Jason Chan, a neurologist at Surrey Memorial Hospital, has been named the recipient of the 2025 Michael Smith Health Research BC Health Professional-Investigator Award. The prestigious honor comes with substantial funding aimed at advancing Parkinson’s disease research and translating…
-
Two Endowed Chairs Poised to Transform Cancer Care in London
Major Gift Fuels Long-Term Cancer Research at Western University Canada faces a sobering reality: almost half of the population is expected to receive a cancer diagnosis in their lifetime. In response, a groundbreaking $5 million donation from the late Archie and Irene Verspeeten, channeled through the London Health Sciences Foundation (LHSF) and matched by Western…
-
LHSF Donation Funds Two Verspeeten Chairs to Accelerate Cancer Research at Western
Major Gift Creates Two Endowed Cancer Research Chairs at Western In a landmark commitment to advancing cancer research, the London Health Sciences Foundation (LHSF), together with the late Archie and Irene Verspeeten, has established two endowed research chairs at Western University’s Schulich School of Medicine & Dentistry. The $5 million donation, matched by Western University,…
-
Two Pivotal Research Chairs Positioned to Transform Cancer Care
Two Endowed Chairs to Accelerate Cancer Breakthroughs In a landmark set of donations and institutional commitments, Western University and London Health Sciences Centre (LHSC) have created two new endowed chairs aimed at transforming cancer care. The gift, totaling $5 million from the late Archie and Irene Verspeeten and matched by Western University, establishes the Verspeeten…
-
A Decade of Discovery and Impact at the Glen: Ten Years of Collaboration and Care
marking a decade of progress In 2015, the Glen site opened its doors with a bold vision: to merge discovery, clinical care, and evaluative research under one roof. Ten years later, that ambition stands as a living reality. The Institute marked its tenth anniversary at the Glen with a commemorative event that brought researchers, trainees,…
-
New Drug Candidates Show Promise for Restoring Myelin in MS
Overview: A hopeful step toward remyelination in MS Multiple sclerosis (MS) is a chronic autoimmune disease characterized by damage to the myelin sheath that insulates nerve fibers. This protective layer is essential for fast and efficient nerve signaling between the brain and body. In MS, the immune system often attacks myelin, leading to a range…